Related Experiment Videos
Identification and characterisation of malignant cells using RT-PCR on single flow-sorted cells
T Rasmussen1, L Honoré, H E Johnsen
1Department of Haematology L, Herlev Hospital, University of Copenhagen, Denmark. thomas.r@inet.uni-c.dk
Medical Oncology (Northwood, London, England)
|October 28, 1998
Summary
We developed a novel method combining RT-PCR and flow cytometry to quantify cells expressing specific genes within defined populations. This technique accurately identifies malignant cells and predicts treatment outcomes in stem cell grafts.
Area of Science:
- Hematology
- Molecular Biology
- Immunology
Background:
- Accurate evaluation of stem cell grafts is crucial for clinical success.
- Phenotypic and molecular characterization of cell populations is essential for understanding disease and treatment efficacy.
Purpose of the Study:
- To develop and validate a method for quantifying gene-expressing cells within phenotypically defined populations.
- To demonstrate the clinical applicability of this method in hematological malignancies.
Main Methods:
- Integration of single-cell reverse transcription polymerase chain reaction (RT-PCR) with flow cytometry.
- Phenotypic cell surface antigen analysis combined with clonal marker (IgH) or fusion gene (BCR/ABL) detection at the single-cell level.
Main Results:
- Successfully identified clonal plasma cells in multiple myeloma based on CD38 and CD45RA expression and IgH gene rearrangement.
- Quantified chimeric fusion gene (BCR/ABL) expression in committed and non-committed stem cells in chronic myeloid leukemia autografts.
- Demonstrated equal expression of BCR/ABL mRNA in both CD34+/CD38+ and CD34+/CD38- stem cell compartments.
Conclusions:
- The combined RT-PCR and flow cytometry method enables precise quantification of gene-expressing cells in phenotypically defined populations.
- This approach is valuable for characterizing malignant cells and predicting the efficacy of antibody-mediated purging strategies.
- The method offers a powerful tool for optimizing stem cell graft evaluation in clinical settings.